Evidence based methods improve compliance in glaucoma patients

Article

Problems with medication persistance and adherence are common among patients with glaucoma and have many possible causes.

"We know glaucoma medications only work if the patients use them, but our efforts to improve poor adherence must recognize that this behavior has no single cause. Understanding the barriers and risk factors for poor adherence and persistence is the first step toward identifying problems and helping patients to improve. Then, we must sustain our interventions with ongoing reinforcement," Dr. Yumori said.

She reviewed the literature on persistence and adherence among glaucoma patients as the basis for providing evidence-based recommendations on methods to improve compliance. Dr. Yumori divided the approaches into four categories: increasing knowledge, providing motivation, improving patient skills, and assuring access/follow-up to medication and eye care.

Dr. Yumori's tips for increasing knowledge are centered on both providing patients with information about their disease and providing ways for optometrists to understand the patients' medication use and existing obstacles. When interacting with patients on these issues, optometrists need to realize that their beliefs and behaviors influence patient adherence. Also, in order to elicit accurate information from their patients, optometrists may need to work to improve their communication skills.

Beginning with the assumption that most patients are non-adherent, optometrists should use open-ended questions formulated with simple language to identify adherence issues. They should also remain nonjudgmental in their reactions to the responses they receive.

"Acknowledge difficulties with adherence and compliment success," she said. "Recognize that English proficiency and health literacy are barriers to adherence and use an interpreter as needed."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.